Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
This study is enrolling participants by invitation only.
Sponsor:
Shanghai Zerun Biotechnology Co.,Ltd
Information provided by (Responsible Party):
Shanghai Zerun Biotechnology Co.,Ltd
ClinicalTrials.gov Identifier:
NCT01548118
First received: February 29, 2012
Last updated: March 5, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |